[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341362-105":59,"doc-detail-341362-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immunotherapeutic-strategies-targeting-breast-cancer-stem-cells","Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells","","Breast cancer remains a leading cause of cancer death in women worldwide despite multiple treatment options, including immunotherapy. This review summarizes current challenges and recent advances aimed at overcoming resistance in breast cancer immunotherapy. It focuses on how signaling pathway inhibition, including Notch, Hedgehog, Hippo, and WNT, regulates breast cancer stem cell self-renewal and drives progression and survival. Breast cancer stem cells can evade immune surveillance and resist immunotherapies, and the review covers their interactions with the immune system, including agents targeting CSC-associated pathways. It also surveys emerging CSC-targeted immunotherapy approaches, including vaccines and adoptive cellular therapies that elicit T cell responses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunotherapeutic-strategies-targeting-breast-cancer-stem-cells/341362/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunotherapeutic-strategies-targeting-breast-cancer-stem-cells/341362.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is breast cancer immunotherapy still challenging?","Question",{"text":112,"@type":113},"Even with multiple treatment options, breast cancer treatment remains challenging due to mechanisms such as resistance and the ability of breast cancer stem cells to evade immune surveillance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role do signaling pathways play in breast cancer stem cells?",{"text":117,"@type":113},"Pathway activity, including Notch, Hedgehog, Hippo, and WNT, regulates the self-renewal and differentiation of breast cancer stem cells, which contributes to disease progression and survival.",{"name":119,"@type":110,"acceptedAnswer":120},"Which immunotherapeutic strategies does the review discuss for targeting breast cancer stem cells?",{"text":121,"@type":113},"The review covers approaches that target CSC-associated signaling pathways and describes emerging strategies such as breast cancer vaccines and adoptive cellular therapies that train the immune system to recognize tumor antigens and generate T cell responses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341362,1790950022,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Review  \nImmunotherapeutic Strategies Targeting Breast Cancer Stem Cells  \nMaria Vasileiou 1, Sotirios Charalampos Diamantoudis 2, Christina Tsianava 3 and Nam P. Nguyen 4, *  \nCitation: Vasileiou, M.; Diamantoudis, S.C.; Tsianava, C.; Nguyen, N.P. Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells. Curr. Oncol. 2024, 31, 3040–3063 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)curroncol31060232  \nReceived: 29 April 2024  \nRevised: 23 May 2024  \nAccepted: 28 May 2024  \nPublished: 29 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece; [mariavasileiou65@gmail.com](mariavasileiou65@gmail.com)  \n2 Department of Pharmacy, School of Health Sciences, Aristotle University of Thessaloniki,  \n54124 Thessaloniki, Greece; [s.c.diamantoudis@gmail.com](s.c.diamantoudis@gmail.com)  \n3 Department of Pharmacy, School of Health Sciences, University of Patras, 26504 Patras, Greece  \n4 Department of Radiation Oncology, Howard University, Washington, DC 20060, USA  \n* [Correspondence: nam.nguyen@howard.edu](Correspondence: nam.nguyen@howard.edu)  \nAbstract: Breast cancer is the most commonly diagnosed cancer in women and is a leading cause of cancer death in women worldwide. Despite the implementation of multiple treatment options, including immunotherapy, breast cancer treatment remains a challenge. In this review, we aim to summarize present challenges in breast cancer immunotherapy and recent advancements in overcoming treatment resistance. We elaborate on the inhibition of signaling cascades, such as the Notch, Hedgehog, Hippo, and WNT signaling pathways, which regulate the self-renewal and differentiation of breast cancer stem cells and, consequently, disease progression and survival. Cancer stem cells represent a rare population of cancer cells, likely originating from non-malignant stem or progenitor cells, with the ability to evade immune surveillance and develop resistance to immunotherapeutic treatments. We also discuss the interactions between breast cancer stem cells and the immune system, including potential agents targeting breast cancer stem cell-associated signaling pathways, and provide an overview of the emerging approaches to breast cancer stem cell-targeted immunotherapy. Finally, we consider the development of breast cancer vaccines and adoptive cellular therapies, which train the immune system to recognize tumor-associated antigens, for eliciting T cell-mediated responses to target breast cancer stem cells.  \nKeywords: immunotherapy; breast cancer; cancer stem cells; immunological profile; CSC-targeted therapies; vaccines; CAR T cells  \n1. Introduction  \nAccording to Global Cancer Observatory (GLOBOCAN) estimates for 2022, breast cancer (BC) is the second most prevalent cancer worldwide (11.6% overall), closely following lung cancer (12.4%) and the fourth lethal overall (6.9% of all cancer-related deaths) behind lung, colorectal, and liver malignancies [1] . BC is responsible for 2.26 million cases and 685,000 deaths globally in 2020 and is predicted to reach 30.19 million cases by 2040 [2] . Breast cancer can be divided into four subtypes based on specific biomarkers. The first type is human epidermal growth factor receptor 2 (HER2) overexpressing, accompanied by positive epidermal growth factor receptor (EGFR) status and negative estrogen receptor (ER) and progesterone receptor (PR) statuses (EGFR+, ER−, and PR−), followed by luminal A (ER+ and PR+, HER2−) and luminal B (ER+ and PR+, HER2+) types. Luminal A tumors typically express high level","cbCaivKBLfnPmuOw","https://ap.wps.com/l/cbCaivKBLfnPmuOw","pdf",893790,24,"English","# Abstract\n# Introduction\n## Breast cancer burden and subtypes\n## Immunogenicity and immunotherapy options","[{\"question\":\"Why is breast cancer immunotherapy still challenging?\",\"answer\":\"Even with multiple treatment options, breast cancer treatment remains challenging due to mechanisms such as resistance and the ability of breast cancer stem cells to evade immune surveillance.\"},{\"question\":\"What role do signaling pathways play in breast cancer stem cells?\",\"answer\":\"Pathway activity, including Notch, Hedgehog, Hippo, and WNT, regulates the self-renewal and differentiation of breast cancer stem cells, which contributes to disease progression and survival.\"},{\"question\":\"Which immunotherapeutic strategies does the review discuss for targeting breast cancer stem cells?\",\"answer\":\"The review covers approaches that target CSC-associated signaling pathways and describes emerging strategies such as breast cancer vaccines and adoptive cellular therapies that train the immune system to recognize tumor antigens and generate T cell responses.\"}]","Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells | PDF",1790041654,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f4b8bef7d088f91c2a3ce77b992b74d.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf83c12815a8509418c6769468020a52.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b844c175a3b0611c3e58e8804a3d3292.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e06923257b4f5dd050af8dfb416ff8e.webp",980,1385]